Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T92328 | ||||
Target Name | Ryanodine receptor 1 (RYR1) | ||||
Type of Target |
Discontinued |
||||
Drug Potency against Target | Dantrolene | Drug Info | Ki = 1500 nM | [2] | |
(O10eq)-Benzyloxycarbonyl-beta-alanylryanodine | Drug Info | IC50 = 5.9 nM | [1] | ||
(O10eq)-beta-alanyl-anhydro-ryanodine | Drug Info | IC50 = 149 nM | [1] | ||
(O10eq)-beta-alanylryanodine | Drug Info | IC50 = 2.6 nM | [1] | ||
(O10eq)-beta-guanidinopropionylryanodine | Drug Info | IC50 = 1.1 nM | [1] | ||
(O10eq)-guanidino acetylryanodine | Drug Info | IC50 = 1.8 nM | [1] | ||
ANHYDRORYANIDINE | Drug Info | IC50 = 8.9 nM | [1] | ||
Benzyloxycarbonyl-glycylryanodine | Drug Info | IC50 = 4.8 nM | [1] | ||
Di-Benzyloxycarbonyl-guanidino acetylryanodine | Drug Info | IC50 = 135.6 nM | [1] | ||
GLYCYLRYANODINE | Drug Info | IC50 = 1.8 nM | [1] | ||
N-methyl ryanodine-succinamidate | Drug Info | IC50 = 49.4 nM | [1] | ||
References | |||||
REF 1 | Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca(2+)-release channel. J Med Chem. 1993 May 14;36(10):1319-23. | ||||
REF 2 | [3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J Med Chem. 1999 Jun 3;42(11):1872-80. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.